De-risking biotech pipelines from model to market | Clinical epidemiology meets translational medicine
Biotech pipeline intelligence. Bilingual podcasts. A peer reviewed video journal. One platform where clinical epidemiology, translational medicine, and radical scientific transparency converge in English and Spanish.
Health Intelligence. Translational Strategy. Regulatory Reality.
At ideas.org.es, our multidisciplinary team brings together PhD-level clinical epidemiology, translational research expertise, and personalized medicine capabilities. We operate at the intersection of public health transformation and biotech innovation.
The accelerating digitalization of healthcare presents both promise and peril—we ensure that technological advances close health inequities rather than deepen them, through skilled leadership, community engagement, and evidence-based prevention. Our foundation in clinical-epidemiological intelligence sets us apart.
Guided by frontline Phase 3 vaccine trial experience (CanSino/ZF2001) and deep expertise in translational medicine, we help biotech ventures, investors, and CROs de-risk pipelines, navigate EMA/AEMPS regulatory pathways, and translate molecular science into real-world patient outcomes. We bridge the macro (public health systems) and the micro (personalized medicine) through our VE²O framework, bilingual podcasts, and global consulting reach.
We don't just study systems; we engineer solutions that work in the clinic, in the community, and at the regulatory table.
Why Choose Us
Multidisciplinary approach
Experienced in working across professional boundaries towards a shared goal
Cultural competence
Capable of forging long-term relationships across cultures and demographics
Versatility & innovation
Highly customizable offers that stand out for the choice of tools and templates
Lower costs for quality
Pricing encourages rollouts, operationalizing and implementation of plans
Expertise
Podcasts
The need for credible sources of real-time health information was acutely felt during recent pandemic. Timely information saves lives and it could be the cornerstone of preparedness against future health emergencies. Achieving it for vast global populations is a formidable undertaking. We bring regular podcasts featuring leaders and experts with proven track record. They offer insightful commentary on global health topics that encourage informed listeners to set the comments section alive! It shapes a healthy discourse on some of the pressing issues that put collective health and wellbeing at risk. Visit our Podcasts page.
Innovations
Development of audiovisual technologies remains robust, representing one of the fastest developing industry. Compared to any time before, modern cameras and their applications are ubiquitous, portable, and integrate seamlessly. These are versatile tools capable of enhancing the trust between client / user and service provider by showing biomedical processes across industry and academia. To promote transparency and reduce biases associated with print-only format, we’ve established Visually Established Experiences & Observations or VE2O, a peer-reviewed video journal of health research.
BioTech Intelligence
Our team—a PhD Clinical Epidemiologist and an MSc expert in Translational Medicine—bridges scientific innovation and business strategy. Powered by Phase 3 vaccine trials (CanSino/ZF2001), UGR training, and CRO experience, we translate molecular data into actionable market intelligence for the Spanish/European biotech ecosystem.
We de-risk pipelines through a clinical-epidemiological lens, flagging flaws in trial design, patient selection, and endpoints before regulators do. From investor deep dives to EMA/AEMPS readiness, we help ventures and CROs make confident, real-world decisions.
Frequently Asked Questions
Everything You Need to Know
What makes IDEAS different from other health consultancies?
Do you work with organizations outside of Europe?
How quickly can we begin after signing up?
Can I upgrade or change my plan mid-engagement?
Is my organization's data and health information secure?
Transparent Pricing
Choose Your Engagement Model
Every plan includes a complimentary 05 minute discovery call. No commitments until we know we’re the right fit for each other.
Health Essentials
Perfect for individual practitioners, small NGOs, and academic researchers starting their global health journey.Professional Impact
For mid size health organizations, research institutes & health systems ready to scale evidence based programs.Government & Institutions
For ministries of health, international agencies, large health systems & multi-country programs requiring comprehensive partnership.Latest Podcasts Playlist
Exploramos los impactos en cascada del envejecimiento, tanto dentro como fuera del cuerpo humano, conectando las luchas personales con las batallas políticas nacionales. Este episodio amplía lo visto en la apertura del 5 de junio de 2026, dentro de la serie de este mes: «El ascenso y ascenso de las personas mayores».
¡Hola! Me encantaría saber qué piensas, envíame un mensaje de voz.
Un ensayo de Fase 3 en primera persona: un centro sin personal formado, una comunidad que confió primero, y Amara, una abuela que hizo la pregunta que nadie podía esquivar.
Y en El Foco: una guía de autocuidado para reducir la resistencia antimicrobiana en casa.
El resto pertenecía a los guardianes.
Any discussion on health spans across disciplines, lifestyles, and age groups.
Beginning June 5 2026, we debut a weekly podcast that sees through updates, upcoming, and even the unforeseen in global health.
We’re excited to bring you an in-depth analysis of our monthly topic, in 4 – to 5 weekly segments. We want this curated presentation of complex health issues to promote evidence-based self-care, a quality marker different from most of the digital content out there. From Granada (Spain), you will be hearing a blend of insightful views, thought provoking statistics, and imaginations worth pursuing. Stay tuned!
Our production team is sold out on the idea of finding evidence to promote all aspects of health. These are curious individuals digging through biomedical landscape, legislative developments, and policy bottlenecks. All of it and much more in fortnightly segments like Spotlight, The Triad, and The Dispatch.
Lead us towards better civic engagement and volunteerism for health-related causes. Everyone is invited to participate. If you listen to the weekly commentary then post your thoughts in comments section of our YouTube Channel https://www.youtube.com/@Populationhealthweekly.
If it sounds interesting to you then spread the word around. And if you’re a hero or a champion willing to showcase your leadership, email us at info@ideas.org.es.
All proceeds and donations to Population Health Weekly (through the hosting platform or https://ideas.org.es/) are dedicated to improve the podcast quality, Lets keep pooling whatever little each of us can……
We are so delighted to begin it all with our official soundtrack, a blend of global beats and rhythms.
Concept: Shehnoor Azhar
Editorial Associate: Erin Rodgers
Technical Support: Wahab Shahid
Podcast logo / Theme Music / Creative & Production Advisor: Imran Babur
While using tools based of Artificial Intelligence, we acknowledge that the AI systems involved were trained on data contributed by countless people and artists. We honor their labor.
All statistics, data, and research findings cited in this podcast are based on the best available evidence at the time of original reporting. As science evolves, some data may be updated, refined, or superseded—and in rare cases, studies may be retracted or corrected by their publishers. We encourage listeners to consult the latest information from trusted sources. This podcast serves as a starting point for understanding complex health issues—not as a substitute for current clinical guidance or official statistics.
Content creator declares no prejudice against an individual, a group, or any entity.
I thought the hardest part was over. Then the real work began.
This is a first-hand account of a large Phase 3 global randomized clinical trial — the stage where a drug proves itself in thousands of patients, or disappears. From a site with no trained staff, one refrigerator on the fourth floor, and a community that trusted us before we trusted ourselves. And Amara, a grandmother who read the consent form slowly and asked the question no one could dodge.
Also: Spotlight — a self-care toolkit for reducing antimicrobial resistance at home. And a memorable 3-liner by Erin Rodgers on the Phase III randomized clinical trials.
The rest belonged to the gatekeepers.
Ready to Make Your Health Program Truly Impactful?
Book a free 05 minute discovery call. No commitment. Just clarity.
IDEASNEWSLETTER
One email a month, distilling everything that mattered — pulled together from our two ongoing bulletins.
- The month's key population-health developments, without the scroll
- Curated by the IDEAS team, not an algorithm
- One short email, once a month — nothing more